Infliximab monograph adopted by European Pharmacopoeia Commission

By Gareth Macdonald contact

- Last updated on GMT

Gettyimages/ultramarine5
Gettyimages/ultramarine5

Related tags: Monoclonal antibodies, European pharmacopoeia, European directorate for the quality of medicines

European Pharmacopoeia Commission has adopted the first monograph for a monoclonal antibody and is poised to add it to the European Pharmacopoeia.

The Commission adopted the “Infliximab concentrated solution” monograph last month​ according to the European Directorate for the Quality of Medicines & HealthCare (EDQM), which said it marked the end of several years of development. 

The Ph. Eur. Commission embarked upon the setting of public standards for therapeutic monoclonal antibodies (mAbs) in 2014 with a pilot phase and following extensive consultation with its stakeholders​.”

The EDQM added that the collaborative approach was required to give the monograph the flexibility needed to accommodate the process-dependent heterogeneity associated with mAbs and their production.

 “The approach used to set the monograph specifications is oriented towards promoting flexibility, notably in addressing process-dependent product heterogeneity.

Significantly, criteria for verifying the performance of analytical methods are included, which will support robust methodologies, while the provision of examples of suitable procedures for complex assays enables the use of alternative methods​,” the directorate said.

The newly adopted infliximab monograph will be included in Pharmacopoeia Supplement 9.6 and will become effective in January 2019.

Related news

Show more

Related products

show more

Single-Step Influenza and Dengue Virus Purification

Single-Step Influenza and Dengue Virus Purification

Bio-Rad Laboratories | 08-Oct-2018 | Application Note

CHT XT is the newest addition to the CHT family of media. It has been designed for superior physical robustness to ensure it can be used repeatedly over...

Cultivation of 3D Cell Aggregates in Perfusion

Cultivation of 3D Cell Aggregates in Perfusion

Eppendorf for Bioprocess – Solutions that grow with you | 17-Sep-2018 | Application Note

3D cell aggregates are of great interest for applications like disease modeling and manufacturing of stem cell-based products. Read more about the cultivation...

Downstream Purification of Large Biomolecules

Downstream Purification of Large Biomolecules

Bio-Rad Laboratories | 17-Sep-2018 | Research Study

Our newest strong anion exchange resin provides both high binding capacity and
high recovery, even at high flow rates. A rigid bead complete with...

Related suppliers

Follow us

Products

View more

Webinars